Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib

OBJECTIVE: Homologous recombination (HR) proficient ovarian cancers, including CCNE1 (cyclin E)-amplified tumors, are resistant to poly (ADP-ribose) polymerase inhibitors (PARPi). Histone deacetylase inhibitors (HDACi) are effective in overcoming tumor resistance to DNA damaging drugs. Our goal was...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gynecol Oncol
Main Authors: Wilson, Andrew J., Sarfo-Kantanka, Kofi, Barrack, Toby, Steck, Alexandra, Saskowski, Jeanette, Crispens, Marta A., Khabele, Dineo
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031537/
https://ncbi.nlm.nih.gov/pubmed/27444036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.07.088
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares